Akari Therapeutics's total assets for Q1 2025 were $50.96M, an increase of 0.79% from the previous quarter. AKTX total liabilities were $29.21M for the fiscal quarter, a 3.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.